Background:
The clinical significance of influenza B is frequently overlooked, and reports on influenza B pneumonia in children are limited. Therefore, the clinical features of associated complications have rarely been reported. The aim of this study is to evaluate the clinical characteristics in pediatric patients with influenza B virus-associated pneumonia. Methods: From January 2009 to February 2012, 389 consecutive patients under 18 years old with influenza B virus infection were enrolled into the study. Thirty-four patients were defined as the pneumonia group by clinical symptoms and chest X-ray (CXR) findings, and 90 patients who had laboratory data and normal CXR findings were recruited to form the nonpneumonia group. Results: The age of the patients in the pneumonia group was significantly younger (median of 5.3 vs. 6.6 years). The white blood cell count (median of 7.5 vs. 5.7 Â 10 9 cells/L) and C-reactive protein level (median of 21.1 vs. 5.7 mg/L) were higher, but the hemoglobin level was lower (median of 12.6 vs. 13.2 g/dL) in the pneumonia group. The CXR findings revealed that 29.4% of patients had alveolar consolidation, 32.4% had interstitial infiltration, and 38.2% had
Introduction
Influenza virus infection is a common pediatric illness, which causes endemic infection with an attack rate of 20e30% in different geographic areas annually. 1e4 The most common symptoms of influenza virus infection are often self-limited, consisting of fever, dry cough, rhinorrhea, headache, and muscle soreness. However, some influenza virus infection results in severe complications, such as pneumonia, myocarditis, and encephalitis. 4e6 These complications of influenza virus infection usually attack patients who are extremely young or old, immunocompromised, or with underlying diseases, such as asthma or neurologic comorbidity.
6e8 Among these complications, pneumonia is the most common and is well known in patients with influenza A virus infection. 6, 9, 10 However, the clinical characteristics of influenza B virus-associated pneumonia, especially in the pediatric population, have rarely been reported. 11 Therefore, in this study, we evaluated the demographic characteristics, clinical presentation, laboratory data, chest X-ray (CXR) findings, and outcomes in pediatric patients with influenza B virus-associated pneumonia.
Materials and Methods
After obtaining approval for the study from the Institutional Review Board, patients under 18 years old diagnosed with influenza B virus infection between January 2009 and February 2012 in Taichung Veterans General Hospital, a tertiary medical center in Taiwan, were consecutively enrolled. Influenza B virus infection was confirmed using the rapid antigen test for detection of influenza virus performed by nasopharyngeal swab, and/or viral throat swab culture, and/or blood sample polymerase chain reaction. Those who had CXR were eligible to be entered into the analysis, and were further divided into two groups, pneumonia and nonpneumonia groups. The enrollment process is shown in Figure 1 . The pneumonia group was defined as patients with fever, clinical symptoms of respiratory tract infection, and obvious infiltrations on CXR examination. 2 The nonpneumonia group comprised patients with the abovementioned symptoms and signs, but normal CXR finding. Patients who had no blood test were excluded.
The medical charts of both investigated groups were reviewed. The demographics, including age, gender, body weight, clinical symptoms, and the durations of fever and oseltamivir use were analyzed. The initial laboratory data, including white blood cell count (WBC) with differential count, platelet count, hemoglobin (Hgb) level, C-reactive protein (CRP) level, and bacterial culture reports were collected. The films of CXR at the time of diagnosis in the pneumonia group were reevaluated by a pediatric radiologist. The findings were described based on the following four features: characteristics of abnormal opacities, distribution of abnormal opacities, unilateral or bilateral of abnormal opacities, and other extrapulmonary changes. 2 The characteristics of abnormal opacities were classified into three types: alveolar consolidation, interstitial infiltration, and ground glass opacity ( Figure 2 ). The distribution of abnormal opacities was divided into diffuse and localized types, the latter of which was further classified into central, peripheral, upper, and lower. The interpretation of the characteristics and distribution of abnormal opacities in each individual depended on the major finding. The clinical courses including total number of days with fever and survival outcome were assessed. Clinical managements, including antimicrobial use, invasive mechanical ventilation support, and extracorporeal membrane oxygenation application, were all investigated.
All continuous data were compared by ManneWhitney Utest, and the categorical data were compared by the Chisquare test within the two groups. A p value less than 0.05 was considered statistically significant.
Results
Among the 389 patients with influenza B virus infection, 185 patients had received CXR examination. Thirty-four patients were assigned to the pneumonia group, and 90 were assigned to the nonpneumonia group. Pneumonia was found in 18.4% (34/185) of influenza B patients who had undergone CXR imaging. The demographic characteristics and clinical features of both groups are summarized in Table 1 . The median age of the pneumonia group was significantly younger than that of the nonpneumonia group: 5.3 versus 6.6 years, respectively (p Z 0.029). The extreme percentiles of body weight distribution, that is, <3rd percentile or >97th percentile, were not different between the two groups (p Z 0.795). At the time of visit, the durations of fever were not significantly different between the two groups. Neither oseltamivir use (5 of 28 and 9 of 80 patients, p Z 0.513) nor doses (8.0 and 8.0 doses, p Z 0.451) before the visit was significantly different between the pneumonia and nonpneumonia groups. The incidences of symptoms in the pneumonia and nonpneumonia groups were as follows: fever, 100% and 94.4%; cough, 97% and 94.4%; and rhinorrhea/nasal congestion, 70.6% and 81.1%, respectively. The incidence of shortness of breath was 14.7% in the pneumonia group and 5.6% in the nonpneumonia group (p Z 0.135). The incidence of abdominal symptoms including abdominal pain, nausea, vomiting and/ or diarrhea was 41.2% for the pneumonia group and 22.2% for the nonpneumonia group (p Z 0.059).
The laboratory data and clinical outcomes of both groups are listed in Table 2 . The WBC of patients in the pneumonia group was significantly higher than that in the nonpneumonia group (7.5 Â 10 9 vs. 5.7 Â 10 9 cells/L, p Z 0.017). The proportion of leukopenia (WBC <4.0 Â 10 9 cells/L) was 14.5% (18/124) for all patients, 5.9% (2/34) in the pneumonia group, and 17.8% (16/90) in the nonpneumonia group. The Hgb level in the pneumonia group was significantly lower than that in the nonpneumonia group, 12.6 and 13.2 g/dL, p Z 0.03. According to the normal range of Hgb level by age, 29.4% (10 of 34) and 11.1% (10 of 90) of patients had anemia in the pneumonia group and nonpneumonia group, respectively (p Z 0.028). The CRP level was also significantly higher in the pneumonia group than in the nonpneumonia group, 21.1 versus 5.7 mg/L (p Z 0.002). Excluding the data of patients with a positive result of bacterial culture, the CRP level was still significantly higher in the pneumonia group, 18.0 versus 5.7 mg/L (p Z 0.010). In the pneumonia group, four patients had a positive result of bacterial culture. One had a blood culture which was positive for Streptococcus pneumoniae, and the other three cultures were from tracheal aspirates, which included two Staphylococcus aureus isolates and one Streptococcus pneumoniae. In the nonpneumonia group, none had a positive result of bacterial culture.
The CXR findings in the pneumonia group are summarized in Table 3 . With regard to the main pattern of characteristics of abnormal opacities, these were varied: 29.4% of patients had alveolar consolidation, 32.4% had interstitial infiltration, and 38.2% had ground glass opacity. Four patients had pleural effusion. Among these four patients, Figure 1 Flowchart of patient selection.
one had Staphylococcus aureus and one had Streptococcus pneumoniae cultured from tracheal aspirates, but no patients had positive culture reports of blood or pleural effusion.
The study further investigated the total durations of fever and antibiotic use in patients with influenza B virus infection-associated pneumonia. Based on the data from 23 patients, there was no significant difference in the total number of days with fever between patients with and without antibiotic treatment (5.0 AE 5.4 days, 17 patients with antibiotic use; 4.5 AE 2.9 days, 6 patients without antibiotic use; p Z 0.245).
Three patients required endotracheal tube intubation. One was a 7-year-old girl who had a history of seizure and presented with status epilepticus, and was then intubated. She recovered without other complications. The other two patients, who died, were previously healthy. They were both intubated because of severe respiratory distress and then further depended on extracorporeal membrane oxygenation support.
Among the four patients with pleural effusion, the first one was a 6-year-old boy who had Streptococcus pneumoniae cultured from tracheal aspirates. He received treatment with peramivir, cefotaxime, and clindamycin, and died of acute respiratory distress syndrome on the 6 th day of hospitalization. The second one was a 14-year-old girl with methicillin-resistant Staphylococcus aureus cultured from tracheal aspirates. She received treatment with peramivir, cefepime, and fosfomycin, and died of myocarditis and multiple organ failure on the 12 th day of hospitalization. The other two patients with pleural effusion were ventilatorindependent, and there was no positive bacterial culture from either blood or pleural effusion. One received combined therapy of 5-day oseltamivir and 7-day cefotaxime plus clindamycin. The other one did not receive any antibiotics. Both of them recovered without any complications. 
Discussion
The influenza B virus was considered to be less virulent and less widespread than the influenza A virus. Thus, previous clinical studies and public health policies have tended to place a greater emphasis on the more pathogenic influenza A virus. 12, 13 However, recent epidemiologic studies have demonstrated that influenza B virus, in a similar manner to influenza A virus, is also capable of causing severe infection and invasive complications. 14, 15 In the present study, pneumonia was found in 18.4% of influenza B patients who had undergone CXR, which was compatible with a previously reported rate of 2e20%. 2, 5 As there are few reports on infection rates in the pediatric population, it is difficult to assess the true mortality rate of pediatric influenza B virus-associated pneumonia. 2, 11, 16 Most patients recovered after adequate treatment, but the mortality rate could be as high as 22e94% if the patients' conditions deteriorate to acute respiratory distress syndrome. 14, 17 In this study, most pneumonia patients recovered with no sequelae, but the patients who developed acute respiratory distress syndrome expired.
The peak age of influenza B virus infection with concomitant pneumonia in children ranged from younger than 1 year to 6 years in different geographic areas. 2, 5, 14 The present study also showed that the median age of the pneumonia group was significantly younger. Moreover, several reports had shown that most serious or fatal cases of influenza B virus-associated pneumonia were not linked with chronic medical conditions. 15, 18 In the present study, the percentages of patients with underlying disease in the two investigated groups were not significantly different. In addition, two deceased patients were previously healthy. Therefore, although greater vigilance in patients with a chronic medical condition is warranted, previously healthy patients should not be presumed to have lower risks of morbidity and mortality.
Early administration of oseltamivir within 48 hours after onset of flulike symptoms is recommended for children at high risk of influenza complications in order to reduce morbidity and mortality. 19 However, the use of oseltamivir against influenza B virus has been reported to have a relatively low clinical effectiveness. 20, 21 Our results also showed no significant difference in oseltamivir use between pneumonia and nonpneumonia patients before the visit.
It is important to identify clues that may indicate the development of complications in patients with influenza B virus infection. Gastrointestinal symptoms, which were common symptoms in children with pneumonia, 22 accounted for the largest proportion of symptoms in the pneumonia group of the current study. With regard to the laboratory findings, the median WBC was higher in the pneumonia group, although leukopenia rates were not significantly different between the two investigated groups. Anemia is relevant to lower respiratory tract infection and for more serious influenza infection. 23, 24 Furthermore, a higher CRP level is considered to be a predictor of bacterial infection among patients with an influenza-like illness. 25, 26 The present study showed lower Hgb and higher CRP level in the pneumonia group regardless of positive or negative bacterial culture reports. Although these results suggest that influenza B virus-associated pneumonia should be considered in patients with higher WBC, lower Hgb, and higher CRP level, the overlapped ranges of these parameters in the two groups were large. Further studies with a larger number of patients are needed to elucidate the precise roles of these parameters.
The CXR findings of patients with influenza virusassociated pneumonia are inconsistently described. 2,15,27e29 In the present study, the CXR findings of pediatric patients with influenza B virus-associated pneumonia were quite varied. Regarding the extrapulmonary changes, pediatric patients with swine flu (H1N1) pneumonia who presented with pleural effusion that could develop without bacterial coinfection and had a mild clinical course. 29 In contrast, two of our four patients with pleural effusion and positive bacterial culture from tracheal aspirates were intubated and died. Therefore, patients who present with pleural effusion and positive bacterial culture from tracheal aspirates may have a risk of mortality.
Influenza virus-associated pneumonia could be classified as primary viral pneumonia, coexisting viral and bacterial pneumonia, and secondary bacterial pneumonia. 2, 25, 30 No clear consensus has been reached about whether patients with viral pneumonia need to be treated with antibiotics. 2, 25 In the present study, there was no significant difference in total number of days with fever in pneumonia patients with and without antibiotic administration. Because of the limited number of patients with a positive bacterial culture report of blood or tracheal aspirates in our study, the timing of combined antiviral and antibacterial therapy for influenza B virus-associated pneumonia should be further investigated.
There were several limitations in this study. The flowchart of patient selection shows that the patients received CXR and blood examinations. Thus, the data only represent patients with influenza B virus infection and more serious conditions. In addition, the present study only included the initial clinical features, laboratory data, and CXR findings, 
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